FDA Inspection 1090288 — Solace Therapeutics, Inc.
The FDA completed an inspection of Solace Therapeutics, Inc. on May 3, 2019 in Framingham, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 3, 2019
- Fiscal Year
- 2019
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Framingham, MA (United States)